Follow
Alaa W. Elmetwalli
Alaa W. Elmetwalli
Clinical Trial Research Unit and Drug Discovery, Egyptian Liver Research Institute and Hospital
Verified email at elriah.com - Homepage
Title
Cited by
Cited by
Year
Global multi-stakeholder endorsement of the MAFLD definition
N Méndez-Sánchez, E Bugianesi, RG Gish, F Lammert, H Tilg, ...
The lancet Gastroenterology & hepatology 7 (5), 388-390, 2022
1892022
Design, synthesis and anticancer evaluation of thieno [2, 3-d] pyrimidine derivatives as dual EGFR/HER2 inhibitors and apoptosis inducers
SA Elmetwally, KF Saied, IH Eissa, EB Elkaeed
Bioorganic chemistry 88, 102944, 2019
1482019
Amygdalin potentiates the anti-cancer effect of Sorafenib on Ehrlich ascites carcinoma and ameliorates the associated liver damage
AA Attia, AF Salama, JG Eldiasty, SAER Mosallam, SA El-Naggar, ...
Scientific Reports 12 (1), 6494, 2022
292022
The potential protective and therapeutic effects of platelet-rich plasma on ischemia/reperfusion injury following experimental torsion/detorsion of testis in the Albino rat model
A Samy, M El-Adl, S Rezk, B Marghani, W Eldomany, A Eldesoky, ...
Life sciences 256, 117982, 2020
262020
Hepatocellular Carcinoma cells: activity of Amygdalin and Sorafenib in Targeting AMPK/mTOR and BCL-2 for anti-angiogenesis and apoptosis cell death
T El-Sewedy, AF Salama, AE Mohamed, NM Elbaioumy, AH El-Far, ...
BMC Complementary Medicine and Therapies 23 (1), 329, 2023
25*2023
Usability and acceptability of self-testing for hepatitis C virus infection among the general population in the Nile Delta region of Egypt
PE Elena Ivanova Reipold, Ahmed Farahat, Amira Elbeeh, Reham Soliman, Alaa ...
BMC Public Health 21, 1-11, 2021
252021
The effect of vitamin B17 on cardiomyopathy against Ehrlich tumor development in female mice
A Elmalla, A Elmetwalli, MES Rizk, AF Salama
Biochemistry Letters 17 (1), 69-76, 2021
22*2021
Thymoquinone, piperine, and sorafenib combinations attenuate liver and breast cancers progression: epigenetic and molecular docking approaches
AA El-Shehawy, A Elmetwalli, AH El-Far, SAER Mosallam, AF Salama, ...
BMC Complementary Medicine and Therapies 23 (1), 69, 2023
21*2023
A risk score to predict 30-day hospital readmission rate in cirrhotic patients with spontaneous bacterial peritonitis
N Mousa, A Abdel-Razik, S Elbaz, M Salah, M Abdelaziz, A Habib, A Deib, ...
European Journal of Medical Research 28 (1), 168, 2023
16*2023
Coagulopathy in COVID-19 from pathogenesis until treatment: a systemic review
N Mousa, A Abdel-Razik, E Mousa, T Elbadrawy, K Hosni, A Mousa, ...
Medical Journal of Viral Hepatitis 5 (2), 3-8, 2021
16*2021
Effect of sorafenib on liver biochemistry prior to vitamin b17 coadministration in ehrlich ascites carcinoma mice model: preliminary phase study
HM Nasser, SA El-Naggar, MESR El-Sayed Rizk, A Elmetwalli, ...
Biochemistry Letters 17 (1), 40-49, 2021
152021
Amygdalin Enhances the Antitumor Effect of Sorafenib
A Elmetwalli, AM Abdel Khalek, SA El-Naggar, MA El-Magd, AF Salama
Egyptian Academic Journal of Biological Sciences, D. Histology …, 2021
12*2021
Evaluation of Bacillus aryabhattai B8W22 peroxidase for phenol removal in waste water effluents
A Elmetwalli, NG Allam, MG Hassan, AN Albalawi, A Shalaby, KS El-Said, ...
BMC microbiology 23 (1), 119, 2023
72023
Ammonia scavenger and glutamine synthetase inhibitors cocktail in targeting mTOR/β-catenin and MMP-14 for nitrogen homeostasis and liver cancer
A Elmetwalli, A Nageh, AI Youssef, M Youssef, MAER Ahmed, ...
Medical Oncology 41 (1), 38, 2023
52023
Novel phloretin-based combinations targeting glucose metabolism in hepatocellular carcinoma through GLUT2/PEPCK axis of action: in silico molecular modelling and in vivo studies
A Elmetwalli, NH Kamosh, R El Safty, AI Youssef, MM Salama, ...
Medical Oncology 41 (1), 12, 2023
42023
Nanoparticle zinc oxide obviates oxidative stress of liver cells in induced-diabetes mellitus model
A Elmetwalli, J Hassan, H Alaa, MG Hassan, M Ali, MF Eltayeb, E Mousa, ...
Medical Journal of Viral Hepatitis 7 (1), 8-12, 2022
32022
Probiotic-derived silver nanoparticles target mTOR/MMP-9/BCL-2/dependent AMPK activation for hepatic cancer treatment
A Elmetwalli, MO Abdel-Monem, AH El-Far, GS Ghaith, NAN Albalawi, ...
Medical Oncology 41 (5), 106, 2024
22024
Gingerol and/or sorafenib attenuates the DAB-induced HCC and hepatic portal vein dilatation via ATG4/CASP3 and COIIV/COX-2/NF-κB expression
AF Salama, AH El-Far, EA Anbar, SA El-Naggar, RM Elshazli, ...
Medical Oncology 41 (2), 57, 2024
22024
Perceptions of medicinal herbal products during the COVID-19 pandemic period among Saudi patients: a cross-sectional study
AN Al Balawi, AR El-Alosey, JG Eldiasty, IYH Abushalfeh, AA Almasaude, ...
Naunyn-Schmiedeberg's Archives of Pharmacology 397 (1), 497-506, 2024
22024
The Impact of Energy Drinks on Liver Health
NF Ismail, G Hamdy, AA Hassan, A Elmetwalli, M Salah, J Hassan
Medical Journal of Viral Hepatitis 7 (3), 1-6, 2023
22023
The system can't perform the operation now. Try again later.
Articles 1–20